News Column

National Center for Nanoscience and Technology Reports Findings in Immunotherapy

February 3, 2014

By a News Reporter-Staff News Editor at Cancer Vaccine Week -- Data detailed on Biotechnology have been presented. According to news reporting originating from Beijing, People's Republic of China, by NewsRx correspondents, research stated, "Exosomes are nanosized vesicles originating from endosomal compartments and secreted by most living cells. In the past decade, exosomes have emerged as potent tools for cancer immunotherapy due to their important roles in modulation of immune responses, and promising results have been achieved in exosome-based immunotherapy."

Our news editors obtained a quote from the research from National Center for Nanoscience and Technology, "The recent rapid progress of nanotechnology, especially on tailored design of nanocarriers for drug delivery based on both passive and active targeting strategies, sheds light on re-engineering native membrane vesicles for enhanced immune regulation and therapy. Applications of nanotechnology toolkits might provide new opportunity not only for value-added therapeutic or diagnostic strategies based on exosomes in cancer immunotherapy, but also new insights for biogenesis and biological relevance of membrane vesicles."

According to the news editors, the research concluded: "This commentary focuses on the recent development and limitations of using exosomes in cancer immunotherapy and our perspectives on how nanomaterials with potential immune regulatory effects could be introduced into exosome-based immunotherapy."

For more information on this research see: How can nanotechnology help membrane vesicle-based cancer immunotherapy development? Human Vaccines & Immunotherapeutics, 2013;9(1):222-5 (see also Biotechnology).

The news editors report that additional information may be obtained by contacting X. Tian, CAS Key Laboratory for Biomedical Effects of Nanomaterials & Nanosafety, National Center for Nanoscience and Technology, Beijing, People's Taiwan. Additional authors for this research include M. Zhu and G. Nie.

Keywords for this news article include: Asia, Biotechnology, Cancer, Beijing, Exosomes, Oncology, Organelles, Immunotherapy, Immunomodulation, Transport Vesicles, Cytoplasmic Structures, People's Republic of China.

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC

For more stories covering the world of technology, please see HispanicBusiness' Tech Channel

Source: Cancer Vaccine Week

Story Tools